Impact of guideline-concordant microbiological testing on outcomes of pneumonia
Hironori Uematsu1, Hideki Hashimoto, Tetsuya Iwamoto
1Department of Health and Social Behavior, School of Public Health, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan. hidehashimoto-circ@umin.ac.jp.
Objective:
Clinical practice guidelines recommend standardized diagnostic microbiological testing for community-acquired pneumonia on hospital admission, although evidence of its impact on quality is limited. This study evaluated the relationship between guideline-concordant microbiological testing (GCMT) and both in-hospital mortality and length of stay.
Design:
/st> Retrospective cohort study using a multicenter claims-based inpatient database linked to a government hospital census database in Japan.
Setting And Participants:
/st> Patients who were diagnosed with and treated for pneumonia, and were discharged between 1 July 2010 and 30 September 2011 (n = 65 145).
Methods:
and
Main Outcome Measures:
/st> GCMT was defined to include sputum tests, blood cultures and urine antigen tests conducted on the first day of hospitalization. We examined the association between 30-day in-hospital mortality and both the performance of each test and the number of tests performed using multivariable logistic regression analysis, adjusting for patient demographics, pneumonia severity and hospital characteristics. Length of stay was analyzed using a Cox proportional hazards model.
Results:
/st> Simultaneous conduct of all three tests was significantly associated with reduced 30-day mortality (odds ratio: 0.64; 95% confidence interval (CI): 0.56-0.74) and with increased likelihood of discharge (hazard ratio: 1.04; 95% CI: 1.00-1.07), after adjusting for patient and hospital characteristics. The association was more marked as the level of disease severity increased.
Conclusions:
/st> Performance of GCMT was significantly associated with lower mortality and shorter length of stay. These results suggest that hospitals should assure performance of GCMT in patients with severe community-acquired pneumonia.
Insights
Standardized microbiological testing for community-acquired pneumonia significantly reduces mortality and length of hospital stay. Adhering to guideline-concordant microbiological testing (GCMT) is crucial for severe pneumonia cases.
Area of Science:
- Infectious Diseases
- Clinical Microbiology
- Health Services Research
Background:
- Clinical practice guidelines recommend standardized diagnostic microbiological testing for community-acquired pneumonia (CAP) upon hospital admission.
- Evidence regarding the impact of such testing on quality of care is limited.
- This study investigates the association between guideline-concordant microbiological testing (GCMT) and patient outcomes.
Purpose of the Study:
- To evaluate the relationship between guideline-concordant microbiological testing (GCMT) and in-hospital mortality for community-acquired pneumonia.
- To assess the impact of GCMT on length of hospital stay for CAP patients.
- To determine if the benefits of GCMT vary with disease severity.
Main Methods:
- Retrospective cohort study utilizing a Japanese multicenter claims-based inpatient database linked to a government hospital census database.
- Included 65,145 patients diagnosed with and treated for pneumonia between July 2010 and September 2011.
- GCMT included sputum tests, blood cultures, and urine antigen tests on day 1 of hospitalization; analyzed using multivariable logistic and Cox proportional hazards models.
Main Results:
- Simultaneous performance of all three GCMT tests was significantly associated with reduced 30-day mortality (OR: 0.64; 95% CI: 0.56-0.74).
- GCMT was also linked to an increased likelihood of discharge (HR: 1.04; 95% CI: 1.00-1.07).
- These associations were more pronounced in patients with increased disease severity.
Conclusions:
- Guideline-concordant microbiological testing in patients with community-acquired pneumonia is significantly associated with lower mortality and shorter hospital stays.
- Hospitals should prioritize the performance of GCMT, especially for patients with severe CAP.
- The findings support the quality impact of standardized diagnostic testing in CAP management.
Related Concept Videos
01:30Pneumonia III: Complications and Assessment
01:14Atypical Pneumonia
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:29Pneumonia I: Introduction
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....